7-dehydro Cholesterol: From Sterol to Translation
2026-08-28
7-dehydro Cholesterol is a mechanistic probe of sterol flux, UVB photobiology, oxidative lipid stress, and DHCR7-linked immunity. New dhcr7 knockout grass carp data show how a cholesterol-biosynthesis node can become an in vivo disease-resistance target, while also defining the limits of cross-species translation.
Dimetridazole Potentiates Cefotaxime in MDR E. coli
2026-08-27
Wei and colleagues show that Dimetridazole can restore cefotaxime activity against a multidrug-resistant Escherichia coli strain through combined effects on membrane integrity, permeability, and fatty acid biosynthesis. The study provides a mechanistic rationale for antibiotic-rescue combinations, while its single-strain and Galleria mellonella design indicates that further validation is needed before translational conclusions.
FLAG tag Peptide Workflow for Gentle Protein Elution
2026-08-27
The FLAG tag Peptide enables gentle, competition-based recovery of tagged recombinant proteins while preserving complexes for detection and functional assays. This workflow shows how to use DYKDDDDK tagging to support purification, enterokinase processing, and mechanistic studies such as HDAC–corepressor reconstitution.
Nav1.5 Ser571 Phosphorylation in Cardiac Aging
2026-08-26
The 2024 reference study identifies Nav1.5 phosphorylation at Ser571 as a mechanistic link between increased late sodium current, delayed ventricular repolarization, and impaired diastolic function during cardiac aging. By combining phosphomimetic and phosphoablated mouse models with electrocardiography, myocyte electrophysiology, calcium imaging, and contractility measurements, the work connects electrical and mechanical features of the aging myopathy and suggests experimental routes for testing late sodium current inhibition.
Ertugliflozin: From Renal Transport to Trial Design
2026-08-26
Ertugliflozin (PF-04971729) is a highly selective SGLT2 inhibitor for connecting renal glucose transport biology with clinically meaningful cardiovascular and kidney endpoints. This guide focuses on assay design, evidence interpretation, and translational boundaries rather than repeating a conventional mechanism or weight-loss review.
GlycoRNA–RBP Domains Enable TAT Cell Entry
2026-08-25
The reference preprint presents evidence that cell-surface RNA-binding proteins and glycoRNAs assemble into extracellular nanoclusters, expanding the conventional view of the plasma membrane beyond transmembrane proteins and glycoconjugates. Perturbation experiments connect these domains to TAT cell penetration and suggest that RNA-dependent surface organization can regulate how cells interact with extracellular macromolecules.
USP42, JNK/p38, and Breast Cancer Apoptosis
2026-08-25
The reference study identifies USP42 as a pro-tumorigenic deubiquitinating enzyme that supports breast cancer cell growth by suppressing JNK/p38-associated apoptosis. Its combination of expression profiling, USP42 silencing, pathway-inhibitor rescue, and xenograft experiments provides a useful mechanistic framework for studying apoptosis resistance, while leaving the direct USP42 substrate in breast cancer unresolved.
hiPSC Intestinal Organoids for Pharmacokinetics
2026-08-24
Saito and colleagues developed a direct three-dimensional culture strategy for generating expandable, cryopreservable intestinal organoids from human induced pluripotent stem cells. The organoids produced intestinal epithelial cells with enterocyte-associated cytochrome P450 and transporter activities, supporting more physiologically relevant in vitro pharmacokinetic studies than conventional models alone.
Lenalidomide: From IMiD to Immune Circuit
2026-08-23
Explore how Lenalidomide (CC-5013) can be used as a mechanistic probe in multiple myeloma research, linking immune modulation with epigenetic control. This guide translates recent DOT1L–STING findings into practical assay design, controls, and readout strategies.
LRPPRC–Dasatinib Synergy in OXPHOS Disruption
2026-08-22
The reference study identifies dasatinib as a synergistic partner for LRPPRC inhibition in OXPHOS-dependent cancer models. Its central mechanistic insight is that the combination blocks OXPHOS at two levels: dasatinib preferentially affects nuclear-encoded OXPHOS genes, whereas LRPPRC inhibition disrupts mitochondrial genome-encoded OXPHOS transcripts.
AZD0156: From ATM Blockade to Metabolic Insight
2026-08-21
AZD0156 is a selective ATM kinase inhibitor that reveals how DNA damage signaling intersects with nutrient scavenging in cancer cells. This article translates the macropinocytosis findings into practical assay, combination-treatment, and interpretation strategies for cancer therapy research.
FAST Nanoparticles for Food-Grade Nutraceutical Delivery
2026-08-21
Cai and colleagues evaluate Facilitated Self-Assembling Technology as a surfactant-free route for producing stable, food-grade nutraceutical nanoparticles. The study shows that hybrid formulations containing EC16, curcumin, and resveratrol can improve colloidal behavior and gastric stability while retaining compatibility in cell-based assays.
Bradykinin: Practical Research Workflow
2026-08-20
Bradykinin (BA5201) helps standardize peptide-based studies of endothelial vasodilation, vascular permeability, tissue smooth muscle contraction, pain mechanisms, and inflammation signaling. It is intended for controlled scientific research workflows only, not for diagnostic, therapeutic, or medical use.
AICAR Workflows for AMPK Metabolism Research
2026-08-20
Use AICAR as a fast, cell-permeable AMPK control for separating energy-signaling effects from upstream biology in hepatic stellate-cell, metabolic disease, and inflammation models. This workflow connects the reference study’s TRPV1–AMPK findings with practical dosing, readout selection, solubility management, and troubleshooting.
SAR131675: From Lymphatics to Fibrosis
2026-08-19
A translational analysis of SAR131675, a selective ATP-competitive VEGFR-3 inhibitor, integrating lymphangiogenesis, tumor biology, and VEGFC-driven hepatic fibrosis research.
458 records 7/31 page Previous Next First page 上5页 678910 下5页 Last page